Pfizer Advances GLP-1 Receptor Agonist PF-06954522 to Phase 1 Trial with Sosei Heptares Collaboration

Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has been notified by Pfizer that it has entered a new oral s...

November 06, 2023 | Monday | News
Aldeyra Therapeutics and AbbVie Sign Exclusive Option Agreement for Reproxalap License

Under the terms of the option agreement, AbbVie has the option to acquire a co-exclusive license to develop, manufacture, and commercialize reproxalap in t...

November 02, 2023 | Thursday | News
Quantum Leap Initiates Phase 2 DCIS Platform Trial with Atossa, Havah, and Menarini

Quantum Leap Healthcare Collaborative (QLHC) announces the enrollment launch for the Re-Evaluating Conditions for Active Surveillance Suitability as Treatm...

October 31, 2023 | Tuesday | News
Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...

October 23, 2023 | Monday | News
EORTC and Menarini Group Initiate Early-Stage Breast Cancer Trial

Trial expected to screen more than 1900 early-stage breast cancer patients at 120+ sites in 12 countries across Europe, commencing in...

October 23, 2023 | Monday | News
GE Healthcare and Novo Nordisk Collaborate on Non-Invasive Diabetes and Obesity Treatment

Personalized peripheral focused ultrasound therapy has potential as non-invasive, non-pharmacological alternative for chronic disease management Encoura...

October 20, 2023 | Friday | News
ERS Genomics completes licensing agreement with Syngene International

ERS Genomics Limited ('ERS') completes licensing agreement with Syngene International, India's leading Contract Research, Development and Manufacturing Org...

October 19, 2023 | Thursday | News
Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries

Advicenne expanded partnership validates Avanzanite’s execution capabilities and unwavering commitment to the smallest countries in Europe. Avanzani...

October 19, 2023 | Thursday | News
Revvity and Element Biosciences Collaborate to Enhance NGS Research Workflow

“This collaboration between Revvity and Element Biosciences seeks to elevate the overall customer experience by providing compelling application-spec...

October 17, 2023 | Tuesday | News
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

A global licensing agreement has been signed for the development and commercialization of SOFIE’s two investigational Gallium-68 and Fluorine-18 Fi...

October 12, 2023 | Thursday | News
Philips and World Stroke Organization partner to improve access to high-quality stroke care

Philips’ leadership in the rapid end-to-end treatment of stroke helping to improve patient outcomes and increase the efficiency of treatment Roy...

October 11, 2023 | Wednesday | News
SOHM Teams Up with University of Arizona for ABBIE Gene-Editing Tech

UACI is a leading science and tech startup incubator that is directly connected to the University of Arizona. The University of Arizona is renowned for it...

October 11, 2023 | Wednesday | News
Be The Match BioTherapies® & Cryoport Join Forces for Cell & Gene Therapy Advancement

 Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport...

October 10, 2023 | Tuesday | News
Agilent Partners with Sarawak Infectious Disease Centre to Advance Research on Tropical Diseases in Malaysia

Agilent announced the signing of a Memorandum of Understanding (MOU) with the Sarawak Infectious Disease Centre (SIDC) in East Malaysia. The agreemen...

October 09, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close